Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Valcour VG, Shikuma CM, Watters MR, Sacktor NC.

AIDS. 2004 Jan 1;18 Suppl 1:S79-86. Review.

2.

HIV infection and dementia in older adults.

Valcour V, Paul R.

Clin Infect Dis. 2006 May 15;42(10):1449-54. Epub 2006 Apr 13.

PMID:
16619159
3.

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N.

Neurology. 2004 Sep 14;63(5):822-7.

4.

Symptomatic distal sensory polyneuropathy in HIV after age 50.

Watters MR, Poff PW, Shiramizu BT, Holck PS, Fast KM, Shikuma CM, Valcour VG.

Neurology. 2004 Apr 27;62(8):1378-83.

PMID:
15111677
5.

Impact of HIV and aging on neuropsychological function.

Wendelken LA, Valcour V.

J Neurovirol. 2012 Aug;18(4):256-63. doi: 10.1007/s13365-012-0094-1. Epub 2012 Apr 14. Review.

6.

Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort.

Valcour VG, Sacktor NC, Paul RH, Watters MR, Selnes OA, Shiramizu BT, Williams AE, Shikuma CM.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):405-10.

PMID:
17099311
7.

[Dementia complex due to HIV disease and aging].

Moulignier A.

Psychol Neuropsychiatr Vieil. 2007 Sep;5(3):193-207. Review. French.

8.

WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al.

Arch Gen Psychiatry. 1994 Jan;51(1):51-61.

PMID:
8279929
9.

Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

De Ronchi D, Faranca I, Berardi D, Scudellari P, Borderi M, Manfredi R, Fratiglioni L.

Arch Neurol. 2002 May;59(5):812-8.

PMID:
12020265
10.

Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus.

Sacktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin E, Miller EN; Multicenter AIDS Cohort Study (MACS).

J Neurovirol. 2010 Oct;16(5):335-41. doi: 10.3109/13550284.2010.504249.

11.

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.

Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK; HIV Neurobehavioral Research Center Group.

AIDS. 2004 Jan 1;18 Suppl 1:S27-34.

PMID:
15075495
12.

Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy.

Cruse B, Cysique LA, Markus R, Brew BJ.

J Neurovirol. 2012 Aug;18(4):264-76. doi: 10.1007/s13365-012-0092-3. Epub 2012 Apr 14. Review.

PMID:
22528476
13.

Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals.

Sacktor N, Skolasky R, Selnes OA, Watters M, Poff P, Shiramizu B, Shikuma C, Valcour V.

J Neurovirol. 2007 Jun;13(3):203-9.

PMID:
17613710
14.

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.

Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M.

J Neurovirol. 2007 Jun;13(3):195-202.

PMID:
17613709
15.

HIV, aging, and cognition: emerging issues.

Valcour VG.

Top Antivir Med. 2013 Jul-Aug;21(3):119-23. Review.

16.

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.

Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P.

J Neurovirol. 2005 Jul;11(3):265-73.

PMID:
16036806
17.

Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence.

Rabkin JG, McElhiney MC, Ferrando SJ.

AIDS. 2004 Jan 1;18 Suppl 1:S43-8. Review.

PMID:
15075497
18.

CD4 counts of HIV-positive patients with cognitive disorders in Japan.

Fukunishi I, Hirabayashi N, Fukutake K.

Psychosomatics. 1999 Nov-Dec;40(6):529. No abstract available.

PMID:
10581986
19.

Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.

McCombe JA, Vivithanaporn P, Gill MJ, Power C.

HIV Med. 2013 Feb;14(2):99-107. doi: 10.1111/j.1468-1293.2012.01043.x. Epub 2012 Sep 20.

20.

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients.

Larussa D, Lorenzini P, Cingolani A, Bossolasco S, Grisetti S, Bongiovanni M, Moretti F, Uccella I, Zannoni P, Foresti S, Mazzarello G, Arcidiacono MI, Pedale R, Ammassari A, Tozzi V, Perno CF, Monforte AD, Cinque P, Antinori A; Italian Registry Investigative Neuro AIDS (IRINA).

AIDS Res Hum Retroviruses. 2006 May;22(5):386-92.

PMID:
16706614

Supplemental Content

Support Center